|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mayo Clinic Jacksonville, Division of Cardiovascular & Thoracic Surgery, 4500 San Pablo Rd, Jacksonville, FL 32224
(Email: odell.john{at}mayo.edu).
The article by Rao and colleagues [1] is another supporting argument that coronary artery bypass grafting is the better option for management of coronary artery disease. I have a poor understanding of the statistical model myself, but I do understand the hypotheses that have been proposed that may play a role. The authors mention that in-stent stenosis is associated with a higher risk of early venous graft failure: the grafts are performed more distally, the discontinuation of antiplatelet medication may result in an in-stent stenosis, and there may be pathophysiologic changes associated with an intravascular foreign body.
There may also be another factor playing a role (ie, intraoperative deformation of the pre-existing stent). This issue has been alluded to by Tovar and colleagues [2] who described a case in which manipulation at surgery deformed a patent vein graft containing stents. As a follow-up to this case, the authors developed an experimental model in pigs [3]. The authors found that pressure over the stented coronary arteries, sufficient to retract the heart, resulted in angioscopic and explant obstruction of the stent, whereas angiographic and radiographic analysis failed to reveal the obstruction. The authors calculated that a force of 4 oz is all that is needed to crush a 4-mm stent, and they suggested that lifting the heart, which usually weighs 11 oz, could result in obliteration of the stents. For this reason, the authors suggested revascularization of all stented vessels, even if they are patent.
I am not aware of any other study that has looked at the fate of the stented and patent vessels which have not been grafted when coronary artery bypass grafting (CABG) is later undertaken. I raise this issue to offer another hypothesis for poor survival in patients having CABG after stenting, and hope that this issue will be further studied.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
C. Rao, T. Athanasiou, and J. Chikwe Reply Ann. Thorac. Surg., September 1, 2008; 86(3): 1052 - 1053. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |